Therefore, the uncovered relationship between TG2 and p53 proposes a possible mechanism by which glucose tolerance abnormality-associated pancreatic cancer may develop and could have therapeutic potential for cancer treatment and diagnosis. This evidence concerns the gene TGM2 and glucose measurement.